Works matching IS 21938210 AND DT 2023 AND VI 13 AND IP 4
Results: 14
Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 1053, doi. 10.1007/s13555-023-00910-6
- By:
- Publication type:
- Article
Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 1039, doi. 10.1007/s13555-023-00909-z
- By:
- Publication type:
- Article
Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 935, doi. 10.1007/s13555-023-00908-0
- By:
- Publication type:
- Article
Living with Psoriasis Vulgaris and Multi-Treatment Failure: A Patient and Dermatologist Perspective.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 857, doi. 10.1007/s13555-023-00907-1
- By:
- Publication type:
- Article
Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 1029, doi. 10.1007/s13555-023-00906-2
- By:
- Publication type:
- Article
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 951, doi. 10.1007/s13555-023-00899-y
- By:
- Publication type:
- Article
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 911, doi. 10.1007/s13555-023-00904-4
- By:
- Publication type:
- Article
Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 891, doi. 10.1007/s13555-023-00903-5
- By:
- Publication type:
- Article
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 1013, doi. 10.1007/s13555-023-00902-6
- By:
- Publication type:
- Article
Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 997, doi. 10.1007/s13555-023-00901-7
- By:
- Publication type:
- Article
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 867, doi. 10.1007/s13555-023-00905-3
- By:
- Publication type:
- Article
Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 981, doi. 10.1007/s13555-023-00897-0
- By:
- Publication type:
- Article
Correction to: Application of Comfort Therapy under eCASH Concept in Acute and Chronic Wound Treatment.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey).
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 961, doi. 10.1007/s13555-022-00850-7
- By:
- Publication type:
- Article